(13-114) Evaluation of Risk Factors for Ifosfamide-Induced Encephalopathy at the Baylor Scott & White Healthcare System
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: Baylor Scott & White Medical Center – Temple / Baylor Scott & White Health Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Texas
Co-Author(s): Robert Marquis, Genevieve Hoffmann, Shane Kyral, Charlotte Farris
